Grufity logo
Grufity logo

Latest Velan Capital Investment Management LP Stock Portfolio

$164Million | No. of Holdings #50

Velan Capital Investment Management LP Performance

2026 Q2+5.97%
YTD+8.52%
2025+23.93%

About Velan Capital Investment Management LP and 13F Hedge Fund Stock Holdings

On 2026-08-14, the fund reported it's updated stock portfolio. In the 13F Holdings report, Velan Capital Investment Management LP reported an equity portfolio of $164.2 Millions as of 30 Jun, 2026. <br><br> The top stock holdings of Velan Capital Investment Management LP are PRAX, , STRO. The fund has invested 18.1% of it's portfolio in PRAXIS PRECISION MEDICINES I and 10.8% of portfolio in MAPLIGHT THERAPEUTICS INC. <br><br> The fund managers got completely rid off ESPERION THERAPEUTICS INC NE (ESPR), KAZIA THERAPEUTICS LTD (KZIA) and ARROWHEAD PHARMACEUTICALS IN (ARWR) stocks. They significantly reduced their stock positions in INSPIREMD INC (NSPR), VIRIDIAN THERAPEUTICS INC (VRDN) and ROCKET PHARMACEUTICALS INC (RCKT). Velan Capital Investment Management LP opened new stock positions in C4 THERAPEUTICS INC (CCCC), ADMA BIOLOGICS INC (ADMA) and REIN THERAPEUTICS INC (ALRN). The fund showed a lot of confidence in some stocks as they added substantially to NEUMORA THERAPEUTICS INC., MACROGENICS INC (MGNX) and AVALO THERAPEUTICS INC (AVTX).
Velan Capital Investment Management LP Equity Portfolio Value
Last Reported on: 14 Aug, 2026
$164Million
  as of Aug 14, 2026

Velan Capital Investment Management LP Annual Return Estimates Vs S&P 500

Our best estimate is that Velan Capital Investment Management LP made a return of 5.97% in the last quarter. In trailing 12 months, it's portfolio return was 69.72%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
c4 therapeutics inc2,661,900
adma biologics inc2,092,500
rein therapeutics inc1,768,000
tectonic therapeutic inc206,250
an2 therapeutics inc193,600
scynexis inc162,800
New stocks bought by Velan Capital Investment Management LP

Additions

Ticker% Inc.
neumora therapeutics inc.187
macrogenics inc100
avalo therapeutics inc75.26
immix biopharma inc46.62
kalaris therapeutics inc38.89
karyopharm therapeutics inc33.33
lyell immunopharma inc2.94
xencor inc2.00
Additions to existing portfolio by Velan Capital Investment Management LP

Reductions

Ticker% Reduced
inspiremd inc-92.94
viridian therapeutics inc-89.03
rocket pharmaceuticals inc-79.64
cytomx therapeutics inc.-77.78
quoin pharmaceuticals ltd-61.85
profound med corp-40.4
context therapeutics inc-40.3
ovid therapeutics inc-18.75
Velan Capital Investment Management LP reduced stake in above stock

Sold off

Ticker$ Sold
esperion therapeutics inc ne-4,712,800
kazia therapeutics ltd-1,006,740
pmv pharmaceuticals inc-90,520
design therapeutics inc-212,800
arrowhead pharmaceuticals in-407,550
Velan Capital Investment Management LP got rid off the above stocks

Sector Distribution

Velan Capital Investment Management LP has about 72.2% of it's holdings in Healthcare sector.

  • Healthcare
  • Others
Sector%
Healthcare72.2
Others27.8

Market Cap. Distribution

Velan Capital Investment Management LP has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.

  • SMALL-CAP
  • UNALLOCATED
  • MID-CAP
  • MICRO-CAP
  • NANO-CAP
Category%
SMALL-CAP34.2
UNALLOCATED27.8
MID-CAP20.3
MICRO-CAP12.7
NANO-CAP5

Stocks belong to which Index?

About 20.8% of the stocks held by Velan Capital Investment Management LP either belong to S&P 500 or RUSSELL 2000 index.

  • Others
  • RUSSELL 2000
Index%
Others79.2
RUSSELL 200020.8
Top 5 Winners (%)%
anteris technologies global
77.5 %
maplight therapeutics inc
76.3 %
RZLT
rezolute inc
70.5 %
KPTI
karyopharm therapeutics inc
60.3 %
nasus pharma ltd
57.7 %
Top 5 Winners ($)$
maplight therapeutics inc
7.6 M
STRO
sutro biopharma inc
4.2 M
anteris technologies global
3.0 M
EDSA
edesa biotech inc
2.4 M
RZLT
rezolute inc
1.6 M
Top 5 Losers (%)%
CNTX
context therapeutics inc
-63.0 %
JSPR
jasper therapeutics inc
-52.0 %
GOSS
gossamer bio inc
-49.9 %
HRTX
heron therapeutics inc
-46.7 %
evommune inc
-42.1 %
Top 5 Losers ($)$
evommune inc
-4.4 M
TARA
protara therapeutics inc
-3.9 M
HRTX
heron therapeutics inc
-3.3 M
JSPR
jasper therapeutics inc
-1.2 M
NSPR
inspiremd inc
-1.0 M

Velan Capital Investment Management LP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Velan Capital Investment Management LP

Velan Capital Investment Management LP has 50 stocks in it's portfolio. About 74.8% of the portfolio is in top 10 stocks. proved to be the most loss making stock for the portfolio. was the most profitable stock for Velan Capital Investment Management LP last quarter.

$163.21MTotal Value
55.00Positions
14 Aug, 2026Last Reported
Current holdings of Current Stock Holdings of Velan Capital Investment Management LP, last reported on 14 Aug, 2026. Select a row with a linked ticker to view its historical trend.
ExpandHoldingsorted ascending% PortfolioShares Held$ Value% Change
KZIA
Kazia Therapeutics Ltd

Kazia Therapeutics Ltd

KZIA
Velan Capital Investment Management LP's holding in Kazia Therapeutics Ltd over time
0%0.00
$0.00
0%
decreased 100 percentsold off